Balo Andrew K 的 Form 4 申報

Dexcom Inc（DXCM），2021/7/8 申報

申報編號: 0001093557-21-000177
申報時間: 2021/7/8
交易日: 2021/7/6
申報延遲: 2 天
10b5-1 計畫: 表單沒有這欄（2023 年以前）

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $127.9 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Balo Andrew KCIK 0001323190	高階主管（*）

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2021/7/6	Common Stock	S賣出處分	−578	$428.51^F2	−$247,678.78	15,805	間接
2021/7/6	Common Stock	S賣出處分	−400	$429.33^F4	−$171,732	15,405	間接
2021/7/6	Common Stock	S賣出處分	−1,710	$430.56^F5	−$736,257.6	13,695	間接
2021/7/6	Common Stock	S賣出處分	−286	$432.05^F6	−$123,566.3	13,409	間接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

This transaction was executed in multiple trades at prices ranging from $428.125 to $429.060. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $429.141 to $429.401. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $430.270 to $430.919. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $431.455 to $432.050. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

備註

*EVP Regulatory Strategy Clinical Affairs and Strategic Partnership Development

看 SEC EDGAR 上的完整原文（在新分頁開啟）